Innoviva Stock (NASDAQ: INVA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 2.38K / 537.39K |
Day Range | - - - |
52 Wk Range | 12.22 - 16.86 |
Market Cap | $1.03B |
P/E Ratio | 7.33 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 38.85% |
Days to Cover | 31.27 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Innoviva (NASDAQ:INVA) through any online brokerage.
Other companies in Innoviva’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and Tarsus Pharmaceuticals (NASDAQ:TARS).
There is no analysis for Innoviva.
Innoviva has a consensus price target of $11.38.
The stock price for Innoviva (NASDAQ: INVA) is $16.43 last updated July 8, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Innoviva.
Innoviva’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
There is no upcoming split for Innoviva.
Innoviva is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.